In contrast, antibodies in paraneoplastic neurological syndromes (PNS) bind to intracellular antigens and therefore cannot cause the disease directly, even though they serve as valuable biomarkers for an underlying tumour (such as Hu, Ri, Yo or Ma2 antibodies). The gene discussed is CDR2; the disease is paraneoplastic neurologic syndrome.